Gene Therapy Patent Suit Against Sarepta Comes To Close
By Adam Lidgett · October 9, 2026, 8:03 PM EDT
Sarepta Therapeutics Inc. no longer has to face a lawsuit accusing it of infringing a University of Pennsylvania gene therapy patent licensed by clinical-stage biotechnology company Regenxbio Inc. after the parties...
To view the full article, register now.